AGP Executive Report
Last update: 9 hours agoBrain Health Breakthrough: Kazakhstan opened Central Asia’s first specialized Brain Research Institute at Al-Farabi KazNU in Almaty, aiming to boost neuroscience research and training using advanced MRI and EEG tools plus AI-assisted medical studies. Diabetes Update: Kazakhstan reported a drop in overall diabetes incidence in Q1 2026 (308.7 per 100,000 vs 313.5 in Q1 2025), citing stronger endocrinology services and more prevention work in primary care. Maternal Care Gains: Maternal mortality fell 43% in the first quarter of 2026 (6.8 vs 12.0 per 100,000 live births), alongside improved early pregnancy monitoring and expanded perinatal center renovation plans. Pharma Investment Surge: Investment in Kazakhstan’s pharmaceutical and medical device manufacturing hit $142.8m in 2025—over triple 2023—supporting modernization, capacity expansion, and localization. Student Tragedy Abroad: Two Indian MBBS students drowned while swimming in Kazakhstan; FAIMA has asked India’s MEA and the embassy for urgent help repatriating the bodies. Public Health & Safety: A deadly Kazzinc plant blast in eastern Kazakhstan was preliminarily linked to violations of technological procedures, with investigations continuing after three workers died.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
